Athanasios Pavlou

Athanasios Pavlou

Auto-generated profile, based on publicly available information

Athanasios Pavlou

Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
JSJae W. Song
Jae W. Song
APAthanasios Pavlou
Athanasios Pavlou
JXJiayu Xiao
Jiayu Xiao
SKScott E. Kasner
Scott E. Kasner
ZFZhaoyang Fan
Zhaoyang Fan
SMSteven R. Messé
Steven R. Messé
Background and Purpose: Intracranial atherosclerotic disease is a common cause of stroke worldwide. Intracranial vessel wall magnetic resonance imaging may be able to identify imaging biomarkers of symptomatic plaque. We performed a meta-analysis to evaluate the strength of association of imaging features of symptomatic plaque leading to downstream ischemic events. Effects on the strength of association were also assessed accounting for possible sources of bias and variability related to study design and magnetic resonance parameters. Methods: PubMed, Scopus, Web of Science, EMBASE, and Cochrane databases were searched up to October 2019. Two independent reviewers extracted data on study design, vessel wall magnetic resonance imaging techniques, and imaging end points. Per-lesion odds ratios (OR) were calculated and pooled using a bivariate random-effects model. Subgroup analyses, sensitivity analysis, and evaluation of publication bias were also performed. Results: Twenty-one articles met inclusion criteria (1750 lesions; 1542 subjects). Plaque enhancement (OR, 7.42 [95% CI, 3.35–16.43]), positive remodeling (OR, 5.60 [95% CI, 2.23–14.03]), T1 hyperintensity (OR, 2.05 [95% CI, 1.27–3.32]), and surface irregularity (OR, 4.50 [95% CI, 1.39–8.57]) were significantly associated with downstream ischemic events. T2 signal intensity was not significant ( P =0.59). Plaque enhancement was significantly associated with downstream ischemic events in all subgroup analyses and showed stronger associations when measured in retrospectively designed studies ( P =0.02), by a radiologist as a rater ( P <0.001), and on lower vessel wall magnetic resonance imaging spatial resolution sequences ( P =0.02). Conclusions: Plaque enhancement, positive remodeling, T1 hyperintensity, and surface irregularity emerged as strong imaging biomarkers of symptomatic plaque in patients with ischemic events. Plaque enhancement remained significant accounting for sources of bias and variability in both study design and instrument. Future studies evaluating plaque enhancement as a predictive marker for stroke recurrence with larger sample sizes would be valuable.

3 May 2021 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
NANathan Arnett
Nathan Arnett
APAthanasios Pavlou
Athanasios Pavlou
MBMorgan P. Burke
Morgan P. Burke
BCBrett L. Cucchiara
Brett L. Cucchiara
RRRennie L. Rhee
Rennie L. Rhee
JSJae W. Song
Jae W. Song

6 September 2021 in Radiology Research and Practice
Verified
Journal Article
Open access
PDF file
APAthanasios Pavlou
Athanasios Pavlou
RKRobert M. Kurtz
Robert M. Kurtz
JSJae W. Song
Jae W. Song
Accuracy is an important parameter of a diagnostic test. Studies that attempt to determine a test’s accuracy can suffer from various forms of bias. As radiology is a diagnostic specialty, many radiologists may design a diagnostic accuracy study or review one to understand how it may apply to their practice. Radiologists also frequently serve as consultants to other physicians regarding the selection of the most appropriate diagnostic exams. In these roles, understanding how to critically appraise the literature is important for all radiologists. The purpose of this review is to provide a framework for evaluating potential sources of study design biases that are found in diagnostic accuracy studies and to explain their impact on sensitivity and specificity estimates. To help the reader understand these biases, we also present examples from the radiology literature.

7 October 2020 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
JSJae W. Song
Jae W. Song
APAthanasios Pavlou
Athanasios Pavlou
MBMorgan P. Burke
Morgan P. Burke
HSHaochang Shou
Haochang Shou
KAKofi-Buaku Atsina
Kofi-Buaku Atsina
SKScott E. Kasner
Scott E. Kasner

11 September 2026 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
CSCody H. Savage
Cody H. Savage
RHRydhwana Hossain
Rydhwana Hossain
JTJames (Mac) Tonascia
James (Mac) Tonascia
APAthanasios Pavlou
Athanasios Pavlou
CRCharles S. Resnik
Charles S. Resnik
ESElana B. Smith
Elana B. Smith

11 November 2022 in medRxiv
Verified
Preprint
Open access
PDF file
KGKonstanze Viktoria Guggenberger
Konstanze Viktoria Guggenberger
APAthanasios Pavlou
Athanasios Pavlou
QCQuy Xuan Cao
Quy Xuan Cao
IBIshaan J. Bhatt
Ishaan J. Bhatt
QCQi N. Cui
Qi N. Cui
JSJae W. Song
Jae W. Song
Objectives: We conducted a systematic review and individual participant data meta-analysis of publications reporting the ophthalmologic presentation, clinical exam, and orbital MRI findings in ocular giant cell arteritis. Methods: PubMed and Cochrane databases were searched up to January 16, 2022. Publications reporting patient-level data on patients with ophthalmologic symptoms, imaged with orbital MRI and diagnosed with biopsy-proven giant cell arteritis were included. Demographics, clinical symptoms, exam, lab, imaging, and outcomes data were extracted. Methodological quality and completeness of reporting of case reports were assessed. Results: Thirty-two studies were included comprising 51 patients (females=24; median age, 76 years). Vision loss (78%) and headache (45%) were commonly reported visual and cranial symptoms. Ophthalmologic presentation was unilateral (41%) or bilateral (59%). Fundus examination most commonly showed disc edema (64%) and pallor (49%). Average visual acuity was very poor (2.28 logMAR ± 2.18). Diagnoses included anterior (61%) and posterior (16%) ischemic optic neuropathy, central retinal artery occlusion (8%) and orbital infarction syndrome (2%). On MRI, enhancement of the optic nerve sheath (53%), intraconal fat (25%), and optic nerve/chiasm (14%) was most prevalent. Among patients with monocular visual symptoms, 38% showed pathologic enhancement in the asymptomatic eye. Six of seven cases reported imaging resolution after treatment on follow-up MRIs. Conclusions: Vision loss, pallid disc edema, and optic nerve sheath enhancement are the most common clinical, fundoscopic and imaging findings reported in patients diagnosed with ocular giant cell arteritis, respectively. MRI may detect subclinical inflammation in the asymptomatic eye and may be an adjunct diagnostic tool. Key Points: Among 32 publications comprising 51 patients with biopsy-proven giant cell arteritis, vision loss, pallid disc edema, and optic nerve sheath enhancement were the most commonly reported clinical, fundoscopic and orbital MRI findings, respectively. Orbital MRI detected subclinical inflammation in the asymptomatic orbit in 38% of giant cell arteritis patients presenting with monocular visual symptoms. MRI may have a diagnostic role in patients with suspected giant cell arteritis and presenting with acute visual symptoms.